🌍·2d agoResearch
First-in-human (phase I) trial of SOL-116, a humanised IgG4 monoclonal antibody targeting bile salt-stimulated lipase, in healthy participants and rheumatoid arthritis patients.
Publisher
E
Europe PMC
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- June 22, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Related coverage
More related coverage
Manchester University NHS Foundation Trust/2h ago
Greater Manchester to drive forward multi-million-pound investment in wearable health technology
Universitätsklinikum Heidelberg/6h ago
Senat der Universität Heidelberg wählt fünf Prorektorinnen und Prorektoren
Universitätsspital Zürich (USZ)/7h ago
Präzisere Therapien dank neuer Datenansätze bei Lymphomen
Universitätsspital Zürich (USZ)/7h ago